A compound of the formula (1) or a pharmaceutically-acceptable salt: (A chemical formula should be inserted here—please see paper copy enclosed herewith) (1) possess glycogen phosphorylase inhibitory activity and accordingly have value in the treatment of disease states associated with increased glycogen phosphorylase activity. Processes for the manufacture of compounds and pharmaceutical compositions containing them are described.
化合物的
化学式(1)或其药学上可接受的盐:(
化学式请参见随附的纸质副本)(1)具有
糖原磷酸化酶抑制活性,因此对于治疗与
糖原磷酸化酶活性增加相关的疾病状态具有价值。本文描述了制备化合物和含有它们的制药组合物的过程。